微生物組定序服務的全球市場：市場規模、佔有率、成長分析、依類型、應用、技術 - 產業預測，2023-2030 年

Global Microbiome Sequencing Services Market Size, Share, Growth Analysis, By Type(Amplicon, whole-genome), By Application(Autoimmune disorder, cancer), By Technology(Sequencing by synthesis, sequencing by ligation) - Industry Forecast 2023-2030

出版日期: 2023年11月28日 | 出版商:

SkyQuest | 英文 157 Pages | 商品交期: 3-5個工作天內

價格

簡介目錄

2021年全球微生物組測序服務市場規模為12.6億美元，從2022年的13.9億美元增長到2030年的31.3億美元，在預測期間（2023-2030年）以10.7%的複合年增長率增長。

在兩個關鍵因素的推動下，全球微生物組定序服務市場預計將在未來幾年顯著成長：對基於基因組的腸道研究的日益關注以及對次世代定序儀(NGS) 的需求不斷成長。微生物組包括人體及其周圍環境中存在的細菌、真菌、病毒和原生生物，已成為研究人員的焦點。宏基因組定序對不同生物體的遺傳資訊進行順序定序，已被用來識別特定微生物組內的微生物。微生物組定序有望顯著改變疾病的診斷、治療和預後，並引起科學界的廣泛關注。 NGS 和生物資訊學演算法等先進方法的整合揭示了微生物組內複雜的相互作用，並徹底改變了臨床微生物學和感染疾病研究。研究機構正在積極開發尖端工具來增強微生物組定序，例如元轉錄檢測器（MTD）和低成本宏基因定序配合措施等。這些旨在簡化資料評估和實現高解析度分析的進步有助於微生物定序服務市場的加速成長。此外，開發具有成本效益的解決方案和降低測試成本預計將推動低收入和新興國家的更廣泛採用，從而推動這些地區的市場擴張。

微生物組定序服務全球市場區隔分析

微生物組定序服務的全球市場依類型、應用、技術和地區進行區隔。根據類型，市場分為放大器、全基因組、鳥槍定序等。根據應用，市場分為自體免疫疾病、癌症、胃腸道疾病等。根據技術，市場分為 SBS、SBL、 Sanger定序等。從區域來看，市場分為北美、歐洲、亞太地區、中東和非洲以及拉丁美洲。

全球微生物組定序服務市場的促進因素

人們越來越認知到微生物組對人類健康和疾病的影響

微生物組定序市場的主要驅動力是人們日益認知到微生物組對人類健康和疾病有深遠的影響。微生物群與多種健康狀況之間存在著明確的聯繫，包括胃腸道疾病、自體免疫疾病和癌症。隨著研究人員和醫療保健專業人員尋求在診斷、治療和個人化醫療方面的應用，這種不斷加深的理解正在推動對微生物組定序服務不斷成長的需求，並推動市場成長。

全球微生物組定序服務市場的抑制因素

微生物組的複雜性和多樣性：微生物組定序市場的一個重要抑制因素源自於微生物組本身固有的複雜性和變異性。微生物組表現出高度多樣性，個體差異受到用餐、生活方式和環境等因素的影響。這種多樣性對微生物組定序資料的標準化和解釋提出了課題。微生物組分析缺乏標準化方案和參考資料資料庫可能會導致不一致並影響觀察的可靠性和可重複性。此外，缺乏對微生物組資料功能影響的了解可能會阻礙普及和利用。克服這些課題並建立強力的調查方法和標準對於微生物定序的持續發展至關重要。

微生物組定序服務的全球市場趨勢

日益關注個人化醫療和精準治療：微生物組定序市場的一個顯著趨勢是越來越關注個人化醫療和精準治療。對微生物組在人類健康中的作用的深入了解將注意力集中在根據個體獨特的微生物組組成客製化治療和干涉措施上。這一趨勢正在推動先進測序技術、生物資訊學工具和資料分析平台的發展，以實現微生物組的準確分析和分析。將微生物組資料與臨床和遺傳資訊結合，有助於考慮個別微生物組資訊的個人化醫療方法，從而實現有針對性和有效的治療性介入。

執行摘要
調查方法
母市場分析
主要市場考察
- 技術分析
- 價格分析
- 供應鏈分析
- 價值鏈分析
- 市場生態系統
- 智慧財產權分析
- 貿易分析
- Start-Ups分析
- 原料分析
- 創新矩陣
- 研發線產品分析
- 總體經濟指標
- 主要投資分析
- 關鍵成功因素
- 競爭程度
市場動態及展望
- 市場動態
  - 促進因素
  - 機會
  - 抑制因素
  - 任務
- 監管形勢
- 波特的分析
- 對未來中斷的特殊考察
全球微生物組定序服務市場：依類型
- 市場概況
- 放大器
- 全基因組
- 鳥槍法定序等
全球微生物組定序服務市場：依應用分類
- 市場概況
- 自體免疫疾病
- 癌症
- 胃腸道疾病等
全球微生物組定序服務市場：依技術分類
- 市場概況
- SBS
- SBL
- Sanger定序等
依地區分類的全球微生物組定序服務市場規模
- 市場概況
- 北美洲
  - 美國
  - 加拿大
- 歐洲
  - 德國
  - 西班牙
  - 法國
  - 英國
  - 其他歐洲國家地區
- 亞太地區
  - 中國
  - 印度
  - 日本
  - 韓國
  - 其他亞太地區
- 拉丁美洲
  - 巴西
  - 其他拉丁美洲地區
- 中東和非洲 (MEA)
  - 海灣合作理事會國家
  - 南非
  - 其他中東/非洲地區
競爭形勢
- 前5名企業對比
- 主要企業市場定位（2021年）
- 主要市場參與者所採取的策略
- 關鍵成功策略
- 近期市集活動
- 主要企業市場佔有率（2021年）
主要企業簡介
- Microbiome Insights Inc.（Canada）
- Baseclear BV（Netherlands）
- Clinical-Microbiomics A/S（Denmark）
- Merieux NutriSciences Corporation（US）
- MR DNA（US）
- Metabiomics Corp.（US）
- Rancho BioSciences（US）
- Second Genome（US）
- Zymo Research Corporation（US）
- uBiome, Inc.（US）
- Illumina, Inc.（US）
- Thermo Fisher Scientific Inc.（US）
- QIAGEN NV（Netherlands）
- Oxford Nanopore Technologies Ltd.（UK）
- BGI Genomics Co., Ltd.（China）
- CosmosID Inc.（US）
- Diversigen Inc.（US）
- Molecular Research LP（US）
- Microbiome Therapeutics, LLC（US）
- Bio-Rad Laboratories, Inc.（US）

簡介目錄

Product Code: SQMIG35J2091

Global Microbiome Sequencing Services Market size was valued at USD 1.26 billion in 2021 and is poised to grow from USD 1.39 billion in 2022 to USD 3.13 billion by 2030, growing at a CAGR of 10.7% in the forecast period (2023-2030).

The global market for microbiome sequencing services is poised for substantial growth in the coming years, driven by two key factors: the increasing focus on genomics-based gut studies and the growing demand for Next-generation Sequencing (NGS). Microbiome, encompassing bacteria, fungi, viruses, and protists in and on the human body and the surrounding environment, has become a focal point for researchers. Metagenomics sequencing, a process involving continuous sequencing of genetic information from diverse organisms, is employed to identify microorganisms within a specific microbiome. Microbiome sequencing holds significant promise in revolutionizing disease diagnosis, treatment, and prognosis, gaining widespread attention in the scientific community. The integration of advanced methodologies like NGS and bioinformatics algorithms has transformed clinical microbiology and infectious disease research, illuminating the intricate interactions within the microbiome. Research institutions are actively developing cutting-edge tools to enhance microbiome sequencing analysis, exemplified by initiatives such as the meta-transcriptome detector (MTD) and low-cost metagenome sequencing technology. These advancements, aimed at simplifying data evaluation and enabling high-resolution analysis, contribute to the accelerating growth of the microbiome sequencing services market. Moreover, the development of cost-effective solutions and declining testing costs is anticipated to drive increased adoption in low-income and emerging countries, fostering market expansion in these regions.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Microbiome Sequencing Services Market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analysed to get the final quantitative and qualitative data.

Global Microbiome Sequencing Services Market Segmental Analysis

The Global Microbiome Sequencing Services Market is segmented by type, application, technology and region. Based on type, the market can be segmented into amplicon, whole-genome, shotgun sequencing and others. Based on application, the market is segmented into autoimmune disorder, cancer, gastrointestinal disorders and others. Based on technology, the market can be segmented into sequencing by synthesis, sequencing by ligation, sanger sequencing and others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Middle East and Africa, and Latin America.

Drivers of the Global Microbiome Sequencing Services Market

Increasing Recognition of Microbiome's Impact on Human Health and Disease

A primary driver for the microbiome sequencing market is the heightened recognition of the microbiome's profound influence on human health and disease. Associations between the microbiome and various health conditions, such as gastrointestinal disorders, autoimmune diseases, and cancer, have been established. This growing understanding prompts a rising demand for microbiome sequencing services as researchers and healthcare professionals explore its applications in diagnosis, treatment, and personalized medicine, propelling market growth.

Restraints in the Global Microbiome Sequencing Services Market

Complexity and Variability of the Microbiome: A significant restraint in the microbiome sequencing market stems from the inherent complexity and variability of the microbiome itself. The microbiome exhibits high diversity, with individual variations influenced by factors like diet, lifestyle, and the environment. This diversity poses challenges in standardizing and interpreting microbiome sequencing data. The absence of standardized protocols and reference databases for microbiome analysis can result in inconsistencies, impacting the reliability and reproducibility of findings. Additionally, the evolving understanding of the functional implications of microbiome data may impede widespread adoption and utilization in clinical settings. Overcoming these challenges and establishing robust methodologies and standards are pivotal for sustained growth in microbiome sequencing.

Market Trends of the Global Microbiome Sequencing Services Market

Increasing Focus on Personalized Medicine and Precision Therapeutics: A noteworthy trend in the microbiome sequencing market is the growing emphasis on personalized medicine and precision therapeutics. Deeper insights into the microbiome's role in human health lead to a focus on tailoring treatments and interventions based on an individual's unique microbiome composition. This trend drives the development of advanced sequencing technologies, bioinformatics tools, and data analytics platforms for accurate profiling and analysis of the microbiome. Integration of microbiome data with clinical and genetic information facilitates personalized medicine approaches, considering an individual's microbiome profile for targeted and effective therapeutic interventions.

Executive Summary
- Market Overview
- Wheel of Fortune
Research Methodology
- Information Procurement
- Secondary & Primary Data Sources
- Market Size Estimation
- Market Assumptions & Limitations
Parent Market Analysis
- Market Overview
- Market Size
- Market Dynamics
  - Drivers
  - Opportunities
  - Restraints
  - Challenges
Key Market Insights
- Technology Analysis
- Pricing Analysis
- Supply Chain Analysis
- Value Chain Analysis
- Ecosystem of the Market
- IP Analysis
- Trade Analysis
- Startup Analysis
- Raw Material Analysis
- Innovation Matrix
- Pipeline Product Analysis
- Macroeconomic Indicators
- Top Investment Analysis
- Key Success Factor
- Degree of Competition
Market Dynamics & Outlook
- Market Dynamics
  - Drivers
  - Opportunities
  - Restraints
  - Challenges
- Regulatory Landscape
- Porters Analysis
  - Competitive rivalry
  - Threat of Substitute Products
  - Bargaining Power of Buyers
  - Threat of New Entrants
  - Bargaining Power of Suppliers
- Skyquest Special Insights on Future Disruptions
  - Political Impact
  - Economic Impact
  - Social Impact
  - Technical Impact
  - Environmental Impact
  - Legal Impact
Global Microbiome Sequencing Services Market by Type
- Market Overview
- Amplicon
- whole-genome
- shotgun sequencing and others
Global Microbiome Sequencing Services Market by Application
- Market Overview
- Autoimmune disorder
- cancer
- gastrointestinal disorders and others
Global Microbiome Sequencing Services Market by Technology
- Market Overview
- Sequencing by synthesis
- sequencing by ligation
- sanger sequencing and others
Global Microbiome Sequencing Services Market Size by Region
- Market Overview
- North America
  - USA
  - Canada
- Europe
  - Germany
  - Spain
  - France
  - UK
  - Rest of Europe
- Asia Pacific
  - China
  - India
  - Japan
  - South Korea
  - Rest of Asia-Pacific
- Latin America
  - Brazil
  - Rest of Latin America
- Middle East & Africa (MEA)
  - GCC Countries
  - South Africa
  - Rest of MEA
Competitive Landscape
- Top 5 Player Comparison
- Market Positioning of Key Players, 2021
- Strategies Adopted by Key Market Players
- Top Winning Strategies
  - By Development
  - By Company
  - By Year
- Recent Activities in the Market
- Key Companies Market Share (%), 2021
Key Company Profiles
- Microbiome Insights Inc. (Canada)
  - Company Overview
  - Business Segment Overview
  - Financial Updates
  - Key Developments
- Baseclear BV (Netherlands)
  - Company Overview
  - Business Segment Overview
  - Financial Updates
  - Key Developments
- Clinical-Microbiomics A/S (Denmark)
  - Company Overview
  - Business Segment Overview
  - Financial Updates
  - Key Developments
- Merieux NutriSciences Corporation (US)
  - Company Overview
  - Business Segment Overview
  - Financial Updates
  - Key Developments
- MR DNA (US)
  - Company Overview
  - Business Segment Overview
  - Financial Updates
  - Key Developments
- Metabiomics Corp. (US)
  - Company Overview
  - Business Segment Overview
  - Financial Updates
  - Key Developments
- Rancho BioSciences (US)
  - Company Overview
  - Business Segment Overview
  - Financial Updates
  - Key Developments
- Second Genome (US)
  - Company Overview
  - Business Segment Overview
  - Financial Updates
  - Key Developments
- Zymo Research Corporation (US)
  - Company Overview
  - Business Segment Overview
  - Financial Updates
  - Key Developments
- uBiome, Inc. (US)
  - Company Overview
  - Business Segment Overview
  - Financial Updates
  - Key Developments
- Illumina, Inc. (US)
  - Company Overview
  - Business Segment Overview
  - Financial Updates
  - Key Developments
- Thermo Fisher Scientific Inc. (US)
  - Company Overview
  - Business Segment Overview
  - Financial Updates
  - Key Developments
- QIAGEN N.V. (Netherlands)
  - Company Overview
  - Business Segment Overview
  - Financial Updates
  - Key Developments
- Oxford Nanopore Technologies Ltd. (UK)
  - Company Overview
  - Business Segment Overview
  - Financial Updates
  - Key Developments
- BGI Genomics Co., Ltd. (China)
  - Company Overview
  - Business Segment Overview
  - Financial Updates
  - Key Developments
- CosmosID Inc. (US)
  - Company Overview
  - Business Segment Overview
  - Financial Updates
  - Key Developments
- Diversigen Inc. (US)
  - Company Overview
  - Business Segment Overview
  - Financial Updates
  - Key Developments
- Molecular Research LP (US)
  - Company Overview
  - Business Segment Overview
  - Financial Updates
  - Key Developments
- Microbiome Therapeutics, LLC (US)
  - Company Overview
  - Business Segment Overview
  - Financial Updates
  - Key Developments
- Bio-Rad Laboratories, Inc. (US)
  - Company Overview
  - Business Segment Overview
  - Financial Updates
  - Key Developments